Skip to main content
. 2021 May 1;13(1):e2021030. doi: 10.4084/MJHID.2021.030

Table 2.

Citofluorimetry markers of the study population.

EMI PATIENTS (%) NON EMI PATIENTS (%) P VALUE
CD56−/CD117− 10 (29) 28 (14%) 0.046
CD56+/CD117− 5 (14%) 9 (5%) 0.042
CD56−/CD117+ 16 (46%) 145 (74%) 0.023
CD117− 15 (43%) 37 (19%) 0.0035
CD56+ 9 (26%) 24 (12%) 0.0612